The British Pharmacopoeia 2019
- The British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products Regulatory Agency (MHRA)
- TSO (The Stationery Office)
New, legally enforced standards, effective from 1 January 2019. All Europoean Pharmacopoeial texts included.
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.
It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
New for the 2019
The BP 2019 supersedes the BP 2019 and becomes legally effective on 1 January 2019. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.
New for the BP 2019
27 new BP monographs, 39 new Ph. Eur. monographs
117 amended BP monographs
Four new monographs for unlicensed formulations and two new monographs for herbal preparations
Two new monographs for biological medicines
One new and six amended BP Veterinary monographs
All monographs from the Ph. Eur. 9th Edition and Supplements 9.1 to 9.5 included
Three in-year online and offline download product updates to integrate the Ph. Eur. Supplements 9.6, 9.7 and 9.8
Single named user download for offline use. No print copy or online access.
(£1,050.00 inc. VAT)
|Format||Online only||Published||01 Aug 2018|
|Availability||Available Immediately||Delivery||Delivery options and charges|